驱动力(838275) - 关于接待机构投资者调研情况的公告

Group 1: Research and Development - The company has a good cash flow and is continuously increasing R&D investment, having launched multiple specialized research projects this year [3] - In 2022, the company added 1 new invention patent and launched several new products, including Xuexue Milk (for ruminants) and organic aloe [4] - The company has developed products that effectively degrade mold in feed materials and enhance blood oxygen levels, improving feed utilization and reducing health costs [4] Group 2: Market Expansion and Product Applications - The company is expanding its applications in the ruminant field and is actively planning to enter the aquaculture sector [3] - The main business focus is on developing, producing, and selling feed additives that enhance animal blood production capabilities [4] - The company has achieved significant results in improving non-specific immunity against seasonal swine fever and has made breakthroughs in treating blue ear disease through blood production technology [4] Group 3: Capital Market Plans - Since its listing on the Beijing Stock Exchange, the company is learning relevant regulations and will consider stock issuance or convertible bonds for acquisitions if suitable targets arise [3]